Sofia Trocchianesi | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Hedgehog-GLI and Notch Pathways Sustain Chemoresistance and Invasiveness in Colorectal Cancer and Their Inhibition Restores Chemotherapy Efficacy	CANCERS	2023
Prospective validation study of a novel integrated pathway based on clinical features, MRI biomarkers and microRNAs for early detection of prostate cancer	EUROPEAN UROLOGY ONCOLOGY	2023
Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION	2023
Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistance	BIOMÉDECINE & PHARMACOTHÉRAPIE	2023
Network analysis identifies circulating miR-155 as predictive biomarker of type 2 diabetes mellitus development in obese patients: a pilot study	SCIENTIFIC REPORTS	2023
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value	BIOMARKER RESEARCH	2023
The endocrine disruptor cadmium modulates the androgen-estrogen receptors ratio and induces inflammatory cytokines in luminal (A) cell models of breast cancer	ENDOCRINE	2023
Identification and Validation of miR-222-3p and miR-409-3p as Plasma Biomarkers in Gestational Diabetes Mellitus Sharing Validated Target Genes Involved in Metabolic Homeostasis	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
Cell-Target-Specific Anti-Inflammatory Effect of Empagliflozin: In Vitro Evidence in Human Cardiomyocytes	FRONTIERS IN MOLECULAR BIOSCIENCES	2022
Hedgehog-GLI signalling promotes chemoresistance through the regulation of ABC transporters in colorectal cancer cells	SCIENTIFIC REPORTS	2020
Role of tissue and circulating microRNA and DNA as biomarkers in medullary thyroid cancer	PHARMACOLOGY & THERAPEUTICS	2020